Including datasets and analytic reports
OM1 PremiOM Atopic Dermatitis (AD)
OM1 PremiOM Psoriasis (PsO)
OM1 PremiOM Psoriatic Arthritis (PsA)
OM1 PremiOM Rheumatoid Arthritis (RA)
OM1 PremiOM Axial Spondyloarthritis (AxSpA)
OM1 PremiOM Lupus (SLE)
OM1 PremiOM Giant Cell Arteritis (GCA)
OM1 PremiOM Juvenile Idiopathic Arthritis (JIA)
Learn more about OM1's Immunology offerings
Understanding the complexities of these systemic inflammatory diseases, and the factors that affect response to treatments, allows us to bring a dynamic new approach to real-world evidence generation to healthcare stakeholders.
If it can’t be found in a code, do you only want to rely on physician recall? Let OM1 help:
Reasons for discontinuation extracted from clinical notes
Patient demographics among discontinuers provide sub-population insights
Patient population numbers that exceed typical market research reports